Cytoplasmic aggregation of mutant FUS causes multistep RNA splicing perturbations in the course of motor neuron pathology

Dysfunction of the RNA-binding protein (RBP) FUS implicated in RNA metabolism can cause amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. Mutations affecting FUS nuclear localization can drive RNA splicing defects and stimulate the formation of non-amyloid inclusions in affected neurons. However, the mechanism by which FUS mutations contribute to the development of ALS remains uncertain. Here we describe a pattern of RNA splicing changes in the dynamics of the continuous proteinopathy induced by mislocalized FUS. We show that the decrease in intron retention of FUS-associated transcripts represents the hallmark of the pathogenesis of ALS and is the earliest molecular event in the course of progression of the disease. As FUS aggregation increases, the pattern of RNA splicing changes, becoming more complex, including a decrease in the inclusion of neuron-specific microexons and induction of cryptic exon splicing due to the sequestration of additional RBPs into FUS aggregates. Crucially, the identified features of the pathological splicing pattern are also observed in ALS patients in both sporadic and familial cases. Our data provide evidence that both a loss of nuclear FUS function due to mislocalization and the subsequent cytoplasmic aggregation of mutant protein lead to the disruption of RNA splicing in a multistep fashion during FUS aggregation.

[1]  T. Iwatsubo,et al.  ALS-linked cytoplasmic FUS assemblies are compositionally different from physiological stress granules and sequester hnRNPA3, a novel modifier of FUS toxicity , 2021, Neurobiology of Disease.

[2]  OUP accepted manuscript , 2022, Nucleic Acids Research.

[3]  Anna L. Brown,et al.  HnRNP K mislocalisation is a novel protein pathology of frontotemporal lobar degeneration and ageing and leads to cryptic splicing , 2021, Acta Neuropathologica.

[4]  P. Khaitovich,et al.  Alternative splicing during mammalian organ development , 2021, Nature Genetics.

[5]  Indrajeet Patil,et al.  ggsignif: R Package for Displaying Significance Brackets for 'ggplot2' , 2021 .

[6]  V. Buchman,et al.  A bioisostere of Dimebon/Latrepirdine delays the onset and slows the progression of pathology in FUS transgenic mice , 2021, CNS neuroscience & therapeutics.

[7]  D. Cleveland,et al.  Wild-type FUS corrects ALS-like disease induced by cytoplasmic mutant FUS through autoregulation , 2020, bioRxiv.

[8]  M. Zavolan,et al.  Aberrant interaction of FUS with the U1 snRNA provides a molecular mechanism of FUS induced amyotrophic lateral sclerosis , 2020, Nature Communications.

[9]  Timothy L. Bailey,et al.  STREME: Accurate and versatile sequence motif discovery , 2020, bioRxiv.

[10]  C. Sephton,et al.  FUS contributes to mTOR-dependent inhibition of translation , 2020, The Journal of Biological Chemistry.

[11]  P. Fratta,et al.  The role of hnRNPs in frontotemporal dementia and amyotrophic lateral sclerosis , 2020, Acta Neuropathologica.

[12]  Anna L. Brown,et al.  FUS ALS-causative mutations impair FUS autoregulation and splicing factor networks through intron retention , 2020, Nucleic acids research.

[13]  Honglin Luo,et al.  Dysregulation of RNA-Binding Proteins in Amyotrophic Lateral Sclerosis , 2020, Frontiers in Molecular Neuroscience.

[14]  M. Freire,et al.  IN VITRO AND IN VIVO MODELS OF AMYOTROPHIC LATERAL SCLEROSIS: AN UPDATED OVERVIEW , 2020, Brain Research Bulletin.

[15]  D. Ito,et al.  Extensive splicing changes in an ALS/FTD transgenic mouse model overexpressing cytoplasmic fused in sarcoma , 2020, Scientific Reports.

[16]  Runan Yao,et al.  ShinyGO: a graphical gene-set enrichment tool for animals and plants , 2019, Bioinform..

[17]  Guangchuang Yu,et al.  Gene Ontology Semantic Similarity Analysis Using GOSemSim. , 2020, Methods in molecular biology.

[18]  S. Andò,et al.  Alternative Splicing of ALS Genes: Misregulation and Potential Therapies , 2019, Cellular and Molecular Neurobiology.

[19]  U. Schmitz,et al.  The changing paradigm of intron retention: regulation, ramifications and recipes , 2019, Nucleic acids research.

[20]  R. Irizarry ggplot2 , 2019, Introduction to Data Science.

[21]  Steven L Salzberg,et al.  Graph-based genome alignment and genotyping with HISAT2 and HISAT-genotype , 2019, Nature Biotechnology.

[22]  I. Bozzoni,et al.  Mutant FUS and ELAVL4 (HuD) Aberrant Crosstalk in Amyotrophic Lateral Sclerosis , 2019, Cell Reports.

[23]  M. Wilkinson Genetic paradox explained by nonsense , 2019, Nature.

[24]  Jinrong Peng,et al.  PTC-bearing mRNA elicits a genetic compensation response via Upf3a and COMPASS components , 2019, Nature.

[25]  S. A. Patten,et al.  RNA Dysregulation in Amyotrophic Lateral Sclerosis , 2019, Front. Genet..

[26]  Debbie,et al.  Overriding FUS autoregulation in mice triggers gain-of-toxic 1 dysfunctions in RNA metabolism and autophagy-lysosome axis 2 3 , 2022 .

[27]  Damian Szklarczyk,et al.  STRING v11: protein–protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets , 2018, Nucleic Acids Res..

[28]  D. A. Bosco Translation dysregulation in neurodegenerative disorders , 2018, Proceedings of the National Academy of Sciences.

[29]  J. Chen,et al.  ALS mutations of FUS suppress protein translation and disrupt the regulation of nonsense-mediated decay , 2018, Proceedings of the National Academy of Sciences.

[30]  C. Shaw,et al.  ALS/FTD-Linked Mutation in FUS Suppresses Intra-axonal Protein Synthesis and Drives Disease Without Nuclear Loss-of-Function of FUS , 2018, Neuron.

[31]  S. Funikov,et al.  FUS(1-359) transgenic mice as a model of ALS: pathophysiological and molecular aspects of the proteinopathy , 2018, neurogenetics.

[32]  Gene W. Yeo,et al.  Transcriptome–pathology correlation identifies interplay between TDP-43 and the expression of its kinase CK1E in sporadic ALS , 2018, Acta Neuropathologica.

[33]  Eric T. Wang,et al.  Mice with endogenous TDP‐43 mutations exhibit gain of splicing function and characteristics of amyotrophic lateral sclerosis , 2018, The EMBO journal.

[34]  K. Lynch,et al.  HnRNP L represses cryptic exons , 2018, RNA.

[35]  Li Li,et al.  Massively Parallel Single Nucleus Transcriptional Profiling Defines Spinal Cord Neurons and Their Activity during Behavior , 2018, Cell reports.

[36]  Daniela C. Zarnescu,et al.  Lost in Translation: Evidence for Protein Synthesis Deficits in ALS/FTD and Related Neurodegenerative Diseases. , 2018, Advances in neurobiology.

[37]  Stephen A. Goutman,et al.  Amyotrophic lateral sclerosis , 2022, Nature Reviews Disease Primers.

[38]  U. Schmitz,et al.  Intron retention enhances gene regulatory complexity in vertebrates , 2017, Genome Biology.

[39]  B. Burke,et al.  Humanized mutant FUS drives progressive motor neuron degeneration without aggregation in ‘FUSDelta14’ knockin mice , 2017, Brain : a journal of neurology.

[40]  Anne-Claude Gingras,et al.  Regulatory Expansion in Mammals of Multivalent hnRNP Assemblies that Globally Control Alternative Splicing , 2017, Cell.

[41]  Mark T. W. Ebbert,et al.  Repetitive element transcripts are elevated in the brain of C9orf72 ALS/FTLD patients , 2017, Human molecular genetics.

[42]  Sebastien M. Weyn-Vanhentenryck,et al.  Microexons: discovery, regulation, and function , 2017, Wiley interdisciplinary reviews. RNA.

[43]  Joshua J. White,et al.  Extensive cryptic splicing upon loss of RBM17 and TDP43 in neurodegeneration models. , 2016, Human molecular genetics.

[44]  J. Chen,et al.  Proteomic analysis of FUS interacting proteins provides insights into FUS function and its role in ALS. , 2016, Biochimica et biophysica acta.

[45]  P. Wong,et al.  PTBP1 and PTBP2 Repress Nonconserved Cryptic Exons. , 2016, Cell reports.

[46]  V. Plagnol,et al.  Quantitative analysis of cryptic splicing associated with TDP-43 depletion , 2016, bioRxiv.

[47]  Norihiro Suzuki,et al.  Mislocated FUS is sufficient for gain-of-toxic-function amyotrophic lateral sclerosis phenotypes in mice. , 2016, Brain : a journal of neurology.

[48]  Gene W. Yeo,et al.  Distinct and shared functions of ALS-associated proteins TDP-43, FUS and TAF15 revealed by multisystem analyses , 2016, Nature Communications.

[49]  Ewout J. N. Groen,et al.  Comparative interactomics analysis of different ALS-associated proteins identifies converging molecular pathways , 2016, Acta Neuropathologica.

[50]  Xiang-Dong Fu,et al.  Toxic gain of function from mutant FUS protein is crucial to trigger cell autonomous motor neuron loss , 2016, The EMBO journal.

[51]  J. Tapia,et al.  ALS-associated mutant FUS induces selective motor neuron degeneration through toxic gain of function , 2016, Nature Communications.

[52]  Claire H. Michel,et al.  ALS/FTD Mutation-Induced Phase Transition of FUS Liquid Droplets and Reversible Hydrogels into Irreversible Hydrogels Impairs RNP Granule Function , 2015, Neuron.

[53]  P. Wong,et al.  TDP-43 repression of nonconserved cryptic exons is compromised in ALS-FTD , 2015, Science.

[54]  Ching-Seng Ang,et al.  FunRich: An open access standalone functional enrichment and interaction network analysis tool , 2015, Proteomics.

[55]  Christian A. Ross,et al.  Distinct brain transcriptome profiles in C9orf72-associated and sporadic ALS , 2015, Nature Neuroscience.

[56]  Qing-Yu He,et al.  ChIPseeker: an R/Bioconductor package for ChIP peak annotation, comparison and visualization , 2015, Bioinform..

[57]  J. Rothstein,et al.  Rodent Models of Amyotrophic Lateral Sclerosis , 2015, Current protocols in pharmacology.

[58]  H. Dvinge,et al.  Widespread intron retention diversifies most cancer transcriptomes , 2015, Genome Medicine.

[59]  William Stafford Noble,et al.  The MEME Suite , 2015, Nucleic Acids Res..

[60]  Gang Chen,et al.  Interaction of amyotrophic lateral sclerosis/frontotemporal lobar degeneration–associated fused-in-sarcoma with proteins involved in metabolic and protein degradation pathways , 2015, Neurobiology of Aging.

[61]  Gene W. Yeo,et al.  ALS-causative mutations in FUS/TLS confer gain- and loss-of-function by altered association with SMN and U1-snRNP , 2015, Nature Communications.

[62]  P. Sharp,et al.  Detained introns are a novel, widespread class of post-transcriptionally spliced introns , 2015, Genes & development.

[63]  Robert J. Weatheritt,et al.  A Highly Conserved Program of Neuronal Microexons Is Misregulated in Autistic Brains , 2014, Cell.

[64]  B. Frey,et al.  Widespread intron retention in mammals functionally tunes transcriptomes , 2014, Genome research.

[65]  Johnathan Cooper-Knock,et al.  Loss of nuclear TDP‐43 in amyotrophic lateral sclerosis (ALS) causes altered expression of splicing machinery and widespread dysregulation of RNA splicing in motor neurones , 2014, Neuropathology and applied neurobiology.

[66]  Morgan L. Maeder,et al.  Pathways disrupted in human ALS motor neurons identified through genetic correction of mutant SOD1. , 2014, Cell stem cell.

[67]  V. Buchman,et al.  Multistep process of FUS aggregation in the cell cytoplasm involves RNA-dependent and RNA-independent mechanisms , 2014, Human molecular genetics.

[68]  Li-Huei Tsai,et al.  ALS-associated mutation FUS-R521C causes DNA damage and RNA splicing defects. , 2014, The Journal of clinical investigation.

[69]  Yan Mei,et al.  The RNA-binding protein hnRNPLL induces a T cell alternative splicing program delineated by differential intron retention in polyadenylated RNA , 2014, Genome Biology.

[70]  G. Hicks,et al.  ALS-Associated FUS Mutations Result in Compromised FUS Alternative Splicing and Autoregulation , 2013, PLoS genetics.

[71]  Ewout J. N. Groen,et al.  ALS-associated mutations in FUS disrupt the axonal distribution and function of SMN. , 2013, Human molecular genetics.

[72]  Robert Gentleman,et al.  Software for Computing and Annotating Genomic Ranges , 2013, PLoS Comput. Biol..

[73]  V. Buchman,et al.  Fused in Sarcoma (FUS) Protein Lacking Nuclear Localization Signal (NLS) and Major RNA Binding Motifs Triggers Proteinopathy and Severe Motor Phenotype in Transgenic Mice , 2013, The Journal of Biological Chemistry.

[74]  Brendan J. Frey,et al.  A compendium of RNA-binding motifs for decoding gene regulation , 2013, Nature.

[75]  W. Shi,et al.  The Subread aligner: fast, accurate and scalable read mapping by seed-and-vote , 2013, Nucleic acids research.

[76]  T. Hortobágyi,et al.  ALS mutant FUS disrupts nuclear localization and sequesters wild-type FUS within cytoplasmic stress granules , 2013, Human molecular genetics.

[77]  Gene W. Yeo,et al.  ALS-linked TDP-43 mutations produce aberrant RNA splicing and adult-onset motor neuron disease without aggregation or loss of nuclear TDP-43 , 2013, Proceedings of the National Academy of Sciences.

[78]  Zheng Yan,et al.  Widespread splicing changes in human brain development and aging , 2013 .

[79]  Helga Thorvaldsdóttir,et al.  Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration , 2012, Briefings Bioinform..

[80]  Thomas R. Gingeras,et al.  STAR: ultrafast universal RNA-seq aligner , 2013, Bioinform..

[81]  Andrew D. Smith,et al.  Site identification in high-throughput RNA-protein interaction data , 2012, Bioinform..

[82]  S. Gygi,et al.  FUS-SMN protein interactions link the motor neuron diseases ALS and SMA. , 2012, Cell reports.

[83]  D. Dickson,et al.  Expression of Fused in sarcoma mutations in mice recapitulates the neuropathology of FUS proteinopathies and provides insight into disease pathogenesis , 2012, Molecular Neurodegeneration.

[84]  Stephanie C Huelga,et al.  Divergent roles of ALS-linked proteins FUS/TLS and TDP-43 intersect in processing long pre-mRNAs , 2012, Nature Neuroscience.

[85]  Yong-jian Liu,et al.  FUS Transgenic Rats Develop the Phenotypes of Amyotrophic Lateral Sclerosis and Frontotemporal Lobar Degeneration , 2011, PLoS genetics.

[86]  I. Mackenzie,et al.  ALS‐associated fused in sarcoma (FUS) mutations disrupt Transportin‐mediated nuclear import , 2010, The EMBO journal.

[87]  L. Petrucelli,et al.  Wild-Type Human TDP-43 Expression Causes TDP-43 Phosphorylation, Mitochondrial Aggregation, Motor Deficits, and Early Mortality in Transgenic Mice , 2010, The Journal of Neuroscience.

[88]  T. Hortobágyi,et al.  Nuclear import impairment causes cytoplasmic trans-activation response DNA-binding protein accumulation and is associated with frontotemporal lobar degeneration. , 2010, Brain : a journal of neurology.

[89]  E. Mugnaini,et al.  FUS‐immunoreactive inclusions are a common feature in sporadic and non‐SOD1 familial amyotrophic lateral sclerosis , 2010, Annals of neurology.

[90]  Z. Wszolek,et al.  De novo truncating FUS gene mutation as a cause of sporadic amyotrophic lateral sclerosis , 2010, Human mutation.

[91]  S. Pereson,et al.  TDP-43 transgenic mice develop spastic paralysis and neuronal inclusions characteristic of ALS and frontotemporal lobar degeneration , 2010, Proceedings of the National Academy of Sciences.

[92]  Aaron R. Quinlan,et al.  Bioinformatics Applications Note Genome Analysis Bedtools: a Flexible Suite of Utilities for Comparing Genomic Features , 2022 .

[93]  Mark D. Robinson,et al.  edgeR: a Bioconductor package for differential expression analysis of digital gene expression data , 2009, Bioinform..

[94]  K. Pollard,et al.  Detection of nonneutral substitution rates on mammalian phylogenies. , 2010, Genome research.

[95]  M. Robinson,et al.  A scaling normalization method for differential expression analysis of RNA-seq data , 2010, Genome Biology.

[96]  Gonçalo R. Abecasis,et al.  The Sequence Alignment/Map format and SAMtools , 2009, Bioinform..

[97]  Xun Hu,et al.  Mutations in FUS, an RNA Processing Protein, Cause Familial Amyotrophic Lateral Sclerosis Type 6 , 2009, Science.

[98]  Xun Hu,et al.  TDP-43 Mutations in Familial and Sporadic Amyotrophic Lateral Sclerosis , 2008, Science.

[99]  José A Ferreira,et al.  The International Journal of Biostatistics The Benjamini-Hochberg Method in the Case of Discrete Test Statistics , 2011 .

[100]  William Stafford Noble,et al.  Quantifying similarity between motifs , 2007, Genome Biology.

[101]  Bruce L. Miller,et al.  Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis , 2006, Science.

[102]  P. Shannon,et al.  Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.

[103]  Christopher B. Burge,et al.  Maximum entropy modeling of short sequence motifs with applications to RNA splicing signals , 2003, RECOMB '03.

[104]  Tom H. Pringle,et al.  The human genome browser at UCSC. , 2002, Genome research.

[105]  N Turner,et al.  Chi-squared test. , 2000, Journal of clinical nursing.